TY  - JOUR
AU  - Alarcón-Payer, Carolina
AU  - Sánchez Suárez, María Del Mar
AU  - Martín Roldán, Alicia
AU  - Puerta Puerta, José Manuel
AU  - Jiménez Morales, Alberto
PY  - 2022
DO  - 10.3390/jpm12101607
SN  - 2075-4426
UR  - http://hdl.handle.net/10668/21388
T2  - Journal of personalized medicine
AB  - Most malignant hematological diseases are generally a consequence of acquired mutations or rearrangements in cell replication processes. Acute myeloid leukemia (AML) is a clinically and molecularly heterogeneous disease that results from acquired...
LA  - en
KW  - acute myeloid leukemia
KW  - biomarkers
KW  - chronic myeloid leukemia
KW  - personalized medicine
KW  - pharmacogenetics
KW  - polymorphisms
KW  - response
KW  - tyrosine kinase inhibitors
TI  - Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia.
TY  - research article
VL  - 12
ER  -